Market entry
We find the markets where your drug has demand and act as your business development team. One agreement covers all of them.
Firstocean is the AI-native platform to plan, launch and scale your asset worldwide.
Tell us about your drugA third of a drug's lifetime value sits outside the US and Europe. Most biotechs never collect it.
We take your drug into every market where it has demand, across the Gulf, Latin America and Southeast Asia, at no upfront cost.
We find the markets where your drug has demand and act as your business development team. One agreement covers all of them.

We secure the price and the reimbursement in every territory we enter, so health systems pay for your innovation.
We move your drug through specialist partners until it reaches every patient who needs it, and we keep it safe on the market for as long as it sells.

1
We assess the assets in your portfolio free, no strings attached. Our models forecast patients, price and the registration route, and we only propose a market where the forecast supports a launch.

2
One agreement. It sets the territories, the supply, and the transfer price. Your intellectual property stays yours. There is no upfront fee.

3
Regulators in our markets now accept FDA and EMA approvals: no local trials, no repeat review. Software drafts each local file from your dossier, a licensed professional approves it, and approval lands in months, not years.

4
We take on price, reimbursement and supply into the channel. You sell through us and keep the best margins of any commercialization partner.

5
Safety, renewals and label maintenance stay with us for as long as the product sells, and a licensed professional approves every safety decision. The agreement does not end at approval.
Pharma veterans and world-class engineers: the first AI-native commercialization team.
Launch costs cut by 80%.
Filed 10x faster.
Not a single hour of your team's time.

Our advisors ran emerging markets at Pfizer and business development at Johnson & Johnson.

A novel drug, across the globe.
Tell us the asset and the stage. You get a free assessment of what it is worth in every market.
